SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
20-Aug-24 6:40 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 19-Aug-24 | Sale (Planned) | 31,747 | $15.28 | $485,094.00 | (15%) 218.3K to 186.56K | |
20-Aug-24 6:40 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 16-Aug-24 | Grant | 62,115 | -- | -- | 40% 156.19K to 218.3K | |
03-May-24 6:00 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 02-May-24 | Planned Option Sale | 11,427 | $16.94 | $193,573.00 | (7%) 166.66K to 155.23K | |
03-May-24 6:00 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 01-May-24 | Option Exercise | 22,391 | -- | -- | 16% 144.27K to 166.66K | |
09-Apr-24 6:00 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 08-Apr-24 | Planned Option Sale | 26,574 | $17.87 | $474,877.00 | (16%) 170.84K to 144.27K | |
09-Apr-24 6:00 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 05-Apr-24 | Option Exercise | 51,999 | -- | -- | 44% 118.84K to 170.84K | |
27-Mar-24 7:58 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 27-Mar-24 | Sale (Planned) | 17,714 | $17.90 | $317,081.00 | (13%) 136.56K to 118.84K | |
27-Mar-24 7:58 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 25-Mar-24 | Grant | 34,666 | -- | -- | 34% 101.89K to 136.56K | |
27-Feb-24 6:02 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 26-Feb-24 | Planned Option Sale | 5,577 | $24.67 | $137,585.00 | (5%) 107.47K to 101.89K | |
27-Feb-24 6:02 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 23-Feb-24 | Option Exercise | 10,946 | -- | -- | 11% 96.52K to 107.47K | |
09-Jan-24 6:00 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 08-Jan-24 | Option Sale | 3,732 | $29.96 | $111,811.00 | (4%) 100.25K to 96.52K | |
09-Jan-24 6:00 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 06-Jan-24 | Option Exercise | 9,528 | -- | -- | 11% 90.72K to 100.25K | |
06-Oct-23 9:59 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 06-Oct-23 | Option Sale | 51,563 | $21.96 | $1,132,320.00 | (37%) 140.69K to 89.13K | |
06-Oct-23 9:59 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 05-Oct-23 | Option Exercise | 103,999 | -- | -- | 283% 36.7K to 140.69K | |
18-Jul-23 6:00 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 14-Jul-23 | Option Exercise | 100,000 | $20.77 | $2,077,000.00 | 273% 36.7K to 136.69K | 9% |
18-Jul-23 6:00 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 14-Jul-23 | Planned Private Option Sale | 100,000 | $30.04 | $3,004,350.00 | (73%) 136.69K to 36.7K | |
13-Jul-23 8:27 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 12-Jul-23 | Sale (Planned) | 55,104 | $25.05 | $1,380,450.00 | (60%) 91.8K to 36.7K | |
13-Jul-23 8:27 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 11-Jul-23 | Private Sale (Planned) | 16,498 | $25.00 | $412,450.00 | (15%) 108.3K to 91.8K | |
02-May-23 10:00 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 01-May-23 | Option Sale | 7,806 | $21.18 | $165,331.00 | (7%) 116.1K to 108.3K | |
02-May-23 10:00 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 29-Apr-23 | Option Exercise | 15,625 | -- | -- | 16% 100.48K to 116.1K | |
07-Apr-23 8:34 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 06-Apr-23 | Option Sale | 8,582 | $18.16 | $155,849.00 | (8%) 109.06K to 100.48K | |
07-Apr-23 8:34 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 05-Apr-23 | Option Exercise | 17,333 | -- | -- | 19% 91.73K to 109.06K | |
27-Feb-23 9:00 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 24-Feb-23 | Option Sale | 3,851 | $18.78 | $72,321.80 | (4%) 95.58K to 91.73K | |
27-Feb-23 9:00 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 23-Feb-23 | Option Exercise | 10,945 | -- | -- | 13% 84.63K to 95.58K | |
10-Jan-23 8:38 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 09-Jan-23 | Option Sale | 3,904 | $17.13 | $66,876.70 | (4%) 88.54K to 84.63K | |
10-Jan-23 8:38 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 06-Jan-23 | Option Exercise | 9,528 | -- | -- | 12% 79.01K to 88.54K | |
05-Jan-23 1:12 PM View: | Bellicum Pharmaceuticals, Inc (BLCM) | 03-Jan-23 | Option Exercise | 74,739 | -- | -- | 120% 62.12K to 136.85K | |
20-Dec-22 5:19 PM View: | AP Pharma Inc. (HRTX) | 16-Dec-22 | Grant | 38,580 | -- | -- | 287% 13.45K to 52.03K | |
18-Oct-22 9:16 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 15-Oct-22 | Option Exercise | 5,938 | -- | -- | 8% 75.88K to 81.81K | |
18-Oct-22 9:16 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 15-Oct-22 | Option Sale | 2,804 | $15.81 | $44,331.20 | (3%) 81.81K to 79.01K | |
02-Sep-22 10:30 AM View: | Bellicum Pharmaceuticals, Inc (BLCM) | 01-Sep-22 | Option Exercise | 43,400 | -- | -- | 232% 18.71K to 62.12K | |
03-May-22 8:58 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 02-May-22 | Option Sale | 5,483 | $18.18 | $99,691.40 | (7%) 81.36K to 75.88K | |
03-May-22 8:58 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 29-Apr-22 | Option Exercise | 15,625 | -- | -- | 24% 65.73K to 81.36K | |
25-Feb-22 5:40 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 23-Feb-22 | Option Exercise | 10,945 | -- | -- | 19% 58.72K to 69.66K | |
25-Feb-22 5:40 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 23-Feb-22 | Option Sale | 3,928 | $23.80 | $93,486.40 | (6%) 69.66K to 65.73K | |
10-Jan-22 6:22 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 06-Jan-22 | Option Exercise | 9,527 | -- | -- | 18% 52.91K to 62.43K | |
10-Jan-22 6:22 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 06-Jan-22 | Market Option Sale | 3,718 | $23.05 | $85,699.90 | (6%) 62.43K to 58.72K | |
06-Jan-22 9:31 AM View: | Bellicum Pharmaceuticals, Inc (BLCM) | 04-Jan-22 | Option Exercise | 18,715 | -- | -- | 100% 0 to 18.71K | |
23-Dec-21 6:55 PM View: | AP Pharma Inc. (HRTX) | 22-Dec-21 | Grant | 10,452 | -- | -- | 348% 3.0K to 13.45K | |
19-Oct-21 5:30 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 18-Oct-21 | Market Option Sale | 2,963 | $17.41 | $51,585.80 | (5%) 55.87K to 52.91K | |
19-Oct-21 5:30 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 15-Oct-21 | Option Exercise | 5,938 | -- | -- | 12% 49.93K to 55.87K | |
30-Apr-21 6:52 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 30-Apr-21 | Market Option Sale | 7,850 | $20.33 | $159,590.00 | (14%) 57.16K to 49.31K | |
30-Apr-21 6:52 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 29-Apr-21 | Option Exercise | 15,625 | -- | -- | 38% 41.54K to 57.16K | |
08-Feb-21 9:00 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 04-Feb-21 | Grant | 31,250 | -- | -- | 264% 11.85K to 43.09K | |
08-Feb-21 9:00 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 04-Feb-21 | Market Sale | 14,195 | $50.61 | $718,409.00 | (33%) 43.09K to 28.9K | |
08-Jan-21 7:28 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 06-Jan-21 | Option Exercise | 9,527 | -- | -- | 52% 18.44K to 27.97K | |
08-Jan-21 7:28 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 06-Jan-21 | Market Option Sale | 3,484 | $53.34 | $185,837.00 | (12%) 27.97K to 24.48K | |
23-Dec-20 4:20 PM View: | AP Pharma Inc. (HRTX) | 21-Dec-20 | Grant | 3,000 | -- | -- | 100% 0 to 3.0K | |
19-Oct-20 5:25 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 16-Oct-20 | Market Option Sale | 2,960 | $42.56 | $125,978.00 | (17%) 17.75K to 14.79K | |
19-Oct-20 5:25 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 15-Oct-20 | Option Exercise | 5,937 | -- | -- | 50% 11.81K to 17.75K |